Navigation Links
VIA Pharmaceuticals Featured at Cambridge Healthtech Institute Discovery on Target 2009 Conference
Date:10/29/2009

harmaceuticals.com/">http://www.viapharmaceuticals.com.

Forward Looking Statements

This press release may contain "forward-looking" statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements relate to future events or to VIA's future financial performance and involve known and unknown risks, uncertainties and other factors that may cause VIA's actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. In some cases, you can identify forward-looking statements by the use of words such as "may," "could," "expect," "intend," "plan," "seek," "anticipate," "believe," "estimate," "predict," "potential," "continue" or the negative of these terms or other comparable terminology. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond VIA's control and which could materially affect actual results, levels of activity, performance or achievements.

Factors that may cause actual results to differ materially from current expectations include, but are not limited to:

  • our ability to comply with the NASDAQ rules for continued listing in order to maintain the listing of our common stock on NASDAQ;
  • our ability to borrow additional amounts under the loan from Bay City Capital, which is subject to the discretion of Bay City Capital;
  • our ability to obtain necessary financing in the near term, including amounts necessary to repay the loan from Bay City Capital by the October 31, 2009 maturity date (or earlier if certain repayment acceleration provisions are triggered);
  • our ability to control our operating expenses;
  • our ability to comply with covenants included in the
    '/>"/>

SOURCE VIA Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Vanda Pharmaceuticals to Announce Third Quarter 2009 Financial Results on November 2, 2009
2. Amira Pharmaceuticals to Present at the BIO Investor Forum in San Francisco
3. Positive Data from Arena Pharmaceuticals Pivotal BLOOM Trial Demonstrate that Lorcaserin Significantly Improved Markers of Cardiovascular Risk and Glycemic Parameters and was not Associated with Depression or Suicidal Ideation
4. DUSA Pharmaceuticals Named to Deloittes 2009 Technology Fast 500 List of Fastest Growing Companies in North America
5. Peregrine Pharmaceuticals Announces Implementation of 1:5 Reverse Stock Split to Take Effect October 19, 2009
6. Proteolix, Inc. to be Acquired By Onyx Pharmaceuticals
7. Amira Pharmaceuticals to Present at Montgomery Healthcare Conference
8. Cadence Pharmaceuticals CEO Ted Schroeder to Present at the JMP Securities Healthcare Focus Conference in New York on October 6, 2009
9. Onyx Pharmaceuticals to Host Investor Briefing Following ECCO/ESMO Oncology Congress
10. Biostar Pharmaceuticals, Inc. to Present at the Maxim Group Growth Conference on September 29 at 2:00pm ET
11. DUSA Pharmaceuticals to Present at the Maxim Group 3rd Annual Growth Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/18/2014)... November 18, 2014 Medicationdiscountcard.com's ... insights, adding to the company's reputation for helping ... the blog has to offer at http://blog.medicationdiscountcard.com/ ... the information concerning the Affordable Care Act and ... to inform the public about a variety of ...
(Date:11/18/2014)... Dennis Thompson HealthDay Reporter ... experimental antibody drug could prove effective at lowering LDL ... with cholesterol-lowering statin medications. That,s the conclusion of ... Association annual meeting in Chicago. The drug, alirocumab, ... widely used alternative to statins, Zetia, said lead researcher ...
(Date:11/18/2014)... News) -- Women who started smoking at a young ... menstrual pain, a new study suggests. About 29 ... has been suspected as a risk factor for severe ... of the new study said. The researchers analyzed ... study of women,s health in Australia. About 14 percent ...
(Date:11/18/2014)... 2014 Global Partnership for ... telehealth platform to bring quality healthcare to populations ... GPT created Global Partnership for TeleHealth Missions (GPTM), ... telehealth network. GPTM focuses specifically on medical ... disaster relief organizations. , Michael D’Ambrosio, ...
(Date:11/18/2014)... Beach, Virginia (PRWEB) November 18, 2014 ... experience frustrating situations with print devices like unforeseen error ... when they don't have time to find another printer ... the issue. The IT department is likely tied up ... familiar? , That’s where Electronic Systems, ...
Breaking Medicine News(10 mins):Health News:Medicationdiscountcard.com Building Virtual Library of Resources to Help Consumers Navigate Healthcare Landscape 2Health News:Experimental Cholesterol-Lowering Drug Effective, Study Reports 2Health News:Experimental Cholesterol-Lowering Drug Effective, Study Reports 3Health News:Study Ties Teen Smoking to Risk of Severe Menstrual Cramps 2Health News:Global Partnership for TeleHealth (GPT) is Focused on Using the telehealth Platform to Bring Quality Healthcare to Populations in Need Worldwide 2Health News:Electronic Systems, providing Managed Print Services (MPS) in Virginia & Outer Banks North Carolina 2
... and two other drugs used to treat influenza appear safe ... Medical Center have found in a retrospective study of 239 ... The study provides "reassuring safety data about commonly used medications," ... April issue of Obstetrics and Gynecology . "A ...
... Gastroenterological Association (AGA) honors several individuals for their ... prestigious recognition awards. "The individuals chosen as ... by their colleagues, demonstrating the highest level of ... A. Hecht, MD, MS, AGAF, AGA Institute president. ...
... ... the Technology & Innovation Business of the Year category for the 2010 Frank G. Berlin, Sr. ... a technological breakthrough in that each cookie contains as much omega-3 fish oil as a filet ... Venice, FL (PRWEB) April ...
... ... abroad to save lives , ... Bethesda, MD (Vocus) -- More than three months after the January 12 earthquake in Haiti, ... initial earthquake leaving between 4,000-6,000 amputees to combat infection, podiatrists have continued to visit the ...
... model of Alzheimer,s disease, researchers at Mount Sinai School of ... oligomers in the brain, rather than the amyloid plaques previously ... The study, which was supported by the "Oligomer Research ... from the Veterans Administration, appears in the journal Annals ...
... ... was initially discovered. It was also diagnosed by a new DNA test performed at Milford ... the scientist/physician/pathologist and his team. , ... Mildford, CT (PRWEB) April 27, 2010 -- As predicted by public health officials, ...
Cached Medicine News:Health News:Study finds that drugs used for treatment of influenza in pregnancy appear to be safe 2Health News:Prestigious recognition award recipients announced by AGA 2Health News:Prestigious recognition award recipients announced by AGA 3Health News:Omega-3 Cookie Company Recognized as Finalist for Prestigious Business Award 2Health News:Podiatrists Tapped As Vital Resource For Global Disaster Relief 2Health News:Podiatrists Tapped As Vital Resource For Global Disaster Relief 3Health News:Alzheimer's memory problems originate with protein clumps floating in the brain, not amyloid plaques 2Health News:New DNA Test Helps Diagnose Early Lyme Disease Case: Milford Hospital Pathologist Alerts Southern Connecticut Physicians 2
(Date:11/18/2014)... Mass. , Nov. 18, 2014 Respiratory ... of the leading medical device and services providers in ... exclusive partner for Respiratory Motion,s innovative respiratory depression monitor, ... Motion and IMI are working together to connect the ... has a long history of bringing innovative medical devices ...
(Date:11/18/2014)... , Nov. 18, 2014  TransCelerate ... its most recent manuscript on Risk-Based Monitoring ... a Quality Control Measure in Clinical Trials ... Therapeutic Innovation & Regulatory Science  (TIRS) journal. ... collaboration with Medidata, the manuscript examines the ...
(Date:11/18/2014)... FT LAUDERDALE, Fla. , November 18, 2014 ... ), a leading solution provider of access control ... the company has joined the Green Rush Alliance ... solutions to  customers and businesses in the Cannabis ... products and services to medical marijuana dispensaries, retailers ...
Breaking Medicine Technology:Prominent Japanese Med Device Provider to be Respiratory Motion's Exclusive Partner for World's #2 Medical Market 2Prominent Japanese Med Device Provider to be Respiratory Motion's Exclusive Partner for World's #2 Medical Market 3Prominent Japanese Med Device Provider to be Respiratory Motion's Exclusive Partner for World's #2 Medical Market 4TransCelerate BioPharma Inc. Publishes Recommendation on Use of Source Data Verification in Risk-Based Monitoring, Releases Third Update on Initiative Progress 2TransCelerate BioPharma Inc. Publishes Recommendation on Use of Source Data Verification in Risk-Based Monitoring, Releases Third Update on Initiative Progress 3Profile Solutions, Inc Joins the Green Rush Alliance 2Profile Solutions, Inc Joins the Green Rush Alliance 3
... 22, 2011 /PRNewswire-Asia/ -- China Health Resource, Inc. (OTCBB: ... (TCM) products, announced robust record breaking quarterly earnings for ... and $1.8 million in net income, a 219% increase ... the third quarter of 2010. This translates to earnings ...
... HILL, N.C., Nov. 21, 2011  In today,s payer-driven market, ... of a new pharmaceutical product. However, sustaining commercial success ... processes that will increase market share after the product ... of practices to manage the challenges of the pull-through ...
Cached Medicine Technology:China Health Resource Announces Record Breaking 3rd Quarter 2011 Financial Results 2China Health Resource Announces Record Breaking 3rd Quarter 2011 Financial Results 3Managed Care Pull-Through Programs Target Physicians, Boost Market Share 2
... Mosaic, the third generation tissue valve ... stented tissue valve available. The Mosaic valve ... experience and is an excellent choice for ... replacement with a tissue valve. For more ...
... bioprosthesis from Medtronic has more ... clinical experience. Worldwide clinical studies ... structural valve deterioration with Hancock® ... is substantially better than results ...
... The Hancock® II bioprosthesis ... 15 years of proven clinical ... that the freedom from structural ... aortic and mitral bioprostheses is ...
Attain Venogram Balloon Catheter....
Medicine Products: